| 标题 |
IBI363 (TAK-928) plus chemotherapy as first-line (1L) treatment for advanced non–small cell lung cancer (NSCLC) |
| 网址 | |
| DOI | |
| 其它 |
期刊:Journal of Clinical Oncology 作者:HaiYan Tu; Yong Wang; Hongxu Liu; Dingzhi Huang; Pei-Rong Ren; et al 出版日期:2026-06-01 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)